Morgan Stanley 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 12:05 pm Sale | 2023-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | MORGAN STANLEY MS | 4,634,346 5.900% | -1,047,137 (-18.43%) | Filing |
| 2023-02-09 2:52 pm Purchase | 2022-12-30 | 13G | Integra LifeSciences Holdings Corporation IART | MORGAN STANLEY MS | 5,681,483 6.800% | 320,012 (+5.97%) | Filing |
| 2022-02-11 11:58 am Purchase | 2021-12-31 | 13G | Integra LifeSciences Holdings Corporation IART | MORGAN STANLEY MS | 5,361,471 6.300% | 5,361,471 (New Position) | Filing |